HMS Holdings Corp. (NASDAQ: HMSY) today announced that on February 20, 2013, Daniel N. Mendelson joined the company’s Board of Directors. Mr. Mendelson is the Chief Executive Officer of Avalere Health, a strategic advisory firm he founded in 2000. He is also presently Adjunct Professor at the Duke University Fuqua School of Business, and serves on the Board of Directors of Coventry Healthcare.
“Dan’s work has put him on the frontline of healthcare policy and business,” commented Bill Lucia, President and CEO of HMS. “We’re excited to welcome Dan to the Board and look forward to accessing his experience and knowledge as we continue to adapt our company to the changing healthcare environment.”
Mr. Mendelson’s areas of expertise include the Affordable Care Act, Medicare and Medicaid reform, and health system integration. Prior to founding Avalere, Mendelson served as Associate Director for Health at the White House Office of Management and Budget (OMB) where he was responsible for the full healthcare portfolio including Medicare and Medicaid. His work included implementation of the Children’s Health Insurance Program, development of the Medicare pharmaceutical benefit, Presidential initiatives in health information technology and medical error prevention and the electronic disease surveillance system.
Mr. Mendelson holds an undergraduate degree from Oberlin College, and a Masters in Public Policy from the Kennedy School of Government at Harvard University.About HMS Holdings Corp. HMS Holdings Corp., through its subsidiaries, is the nation's leader in coordination of benefits and program integrity services for healthcare payers. HMS's clients include health and human services programs in more than 40 states; commercial programs, including commercial plans, employers, and more than 148 Medicaid managed care plans; the Centers for Medicare and Medicaid Services (CMS); and Veterans Administration facilities. As a result of the company's services, clients recovered $3.2 billion in 2012, and saved billions more through the prevention of erroneous payments.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts